Skip to main content
OpenTrials
Completed

NCT Number: NCT02331329

Evaluation of NICOM (Bioreactance) for the Non-invasive Determination of Cardiac Output

Cardiac output (CO) is an important parameter in the diagnosis and therapy of cardiac diseases. The current standard methods for the determination of CO, however, are either invasive (e.g. right heart catheterization) or technically expendable and expensive (magnetic resonance tomography, MRT). Therefore, the aim of the study at hand was to evaluate NICOM (bioreactance) as a new method for determinion of CO and to compare this new technique to MRT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiac Disease Cardiovascular Diseases Heart Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • indication for cardiac magnetic resonance imaging

Exclusion criteria

  • pace maker
  • patient unwilling to participate

Treatment and study plan

NICOM cardiac output measurement

Device

Cardiac MRT cardiac output measurement

Device

Primary outcomes

  1. agreement of NICOM and MRT cardiac output measurements

    Time frame: at time of inclusion

  2. precision of NICOM cardiac output measurements

    Time frame: at time of inclusion

Sponsors and collaborators

Lead sponsor

Universitätsmedizin Mannheim

Other

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Jan 6, 2015
Registry last updated
Jan 6, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.